These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 38036980)

  • 61. Protein containing synthetic surfactant versus animal derived surfactant extract for the prevention and treatment of respiratory distress syndrome.
    Pfister RH; Soll RF; Wiswell T
    Cochrane Database Syst Rev; 2007 Jul; (3):CD006069. PubMed ID: 17636826
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Surfactant administration without intubation in preterm infants with respiratory distress syndrome--our experiences.
    Krajewski P; Chudzik A; Strzałko-Głoskowska B; Górska M; Kmiecik M; Więckowska K; Mesjasz A; Sieroszewski P
    J Matern Fetal Neonatal Med; 2015 Jul; 28(10):1161-4. PubMed ID: 25065621
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Characteristics of respiratory distress syndrome in infants of different gestational ages.
    Sun H; Xu F; Xiong H; Kang W; Bai Q; Zhang Y; Zhou C; Zhuang F; Wang X; Zhu C
    Lung; 2013 Aug; 191(4):425-33. PubMed ID: 23722460
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Lung recruitment improves the efficacy of intubation-surfactant-extubation treatment for respiratory distress syndrome in preterm neonates, a randomized controlled trial.
    Yang Y; Yan W; Ruan M; Zhang L; Su J; Deng H; Li M
    BMC Pediatr; 2022 Jan; 22(1):14. PubMed ID: 34980047
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The Provo multicenter early high-frequency oscillatory ventilation trial: improved pulmonary and clinical outcome in respiratory distress syndrome.
    Gerstmann DR; Minton SD; Stoddard RA; Meredith KS; Monaco F; Bertrand JM; Battisti O; Langhendries JP; Francois A; Clark RH
    Pediatrics; 1996 Dec; 98(6 Pt 1):1044-57. PubMed ID: 8951252
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Less invasive surfactant administration via infant feeding tube versus InSurE method in preterm infants: a randomized control trial.
    Anand R; Nangia S; Kumar G; Mohan MV; Dudeja A
    Sci Rep; 2022 Dec; 12(1):21955. PubMed ID: 36535971
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome among very preterm infants.
    Moya FR; Gadzinowski J; Bancalari E; Salinas V; Kopelman B; Bancalari A; Kornacka MK; Merritt TA; Segal R; Schaber CJ; Tsai H; Massaro J; d'Agostino R;
    Pediatrics; 2005 Apr; 115(4):1018-29. PubMed ID: 15805380
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Effect of natural surfactant on mortality and morbidity in neonates with a birth weight below 1500 grams].
    Stranák Z; Janota J; Miletín J; Simák J
    Ceska Gynekol; 2000 Dec; 65 Suppl 1():38-42. PubMed ID: 11394231
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Surfactant therapy in preterm infants with respiratory distress syndrome and in near-term or term newborns with acute RDS.
    Ramanathan R
    J Perinatol; 2006 May; 26 Suppl 1(Suppl 1):S51-6; discussion S63-4. PubMed ID: 16625226
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Randomized controlled trial of two methods of nasal continuous positive airway pressure (N-CPAP) in preterm infants with respiratory distress syndrome: underwater bubbly CPAP vs. Medijet system device.
    Hosseini MB; Heidarzadeh M; Balila M; Ghojazadeh M; Janani R; Safavi-nia S; Naghavi-Behzad M; Alikhah H
    Turk J Pediatr; 2012; 54(6):632-40. PubMed ID: 23692790
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparison of Three Different Administration Positions for Intratracheal Beractant in Preterm Newborns with Respiratory Distress Syndrome.
    Karadag A; Ozdemir R; Degirmencioglu H; Uras N; Dilmen U; Bilgili G; Erdeve O; Cakir U; Atasay B
    Pediatr Neonatol; 2016 Apr; 57(2):105-12. PubMed ID: 26190853
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Lung recruitment before surfactant administration in extremely preterm neonates with respiratory distress syndrome (IN-REC-SUR-E): a randomised, unblinded, controlled trial.
    Vento G; Ventura ML; Pastorino R; van Kaam AH; Carnielli V; Cools F; Dani C; Mosca F; Polglase G; Tagliabue P; Boni L; Cota F; Tana M; Tirone C; Aurilia C; Lio A; Costa S; D'Andrea V; Lucente M; Nigro G; Giordano L; Roma V; Villani PE; Fusco FP; Fasolato V; Colnaghi MR; Matassa PG; Vendettuoli V; Poggi C; Del Vecchio A; Petrillo F; Betta P; Mattia C; Garani G; Solinas A; Gitto E; Salvo V; Gargano G; Balestri E; Sandri F; Mescoli G; Martinelli S; Ilardi L; Ciarmoli E; Di Fabio S; Maranella E; Grassia C; Ausanio G; Rossi V; Motta A; Tina LG; Maiolo K; Nobile S; Messner H; Staffler A; Ferrero F; Stasi I; Pieragostini L; Mondello I; Haass C; Consigli C; Vedovato S; Grison A; Maffei G; Presta G; Perniola R; Vitaliti M; Re MP; De Curtis M; Cardilli V; Lago P; Tormena F; Orfeo L; Gizzi C; Massenzi L; Gazzolo D; Strozzi MCM; Bottino R; Pontiggia F; Berardi A; Guidotti I; Cacace C; Meli V; Quartulli L; Scorrano A; Casati A; Grappone L; Pillow JJ
    Lancet Respir Med; 2021 Feb; 9(2):159-166. PubMed ID: 32687801
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Short-term outcome of pulmonary hemorrhage in very-low-birth-weight preterm infants.
    Yen TA; Wang CC; Hsieh WS; Chou HC; Chen CY; Tsao PN
    Pediatr Neonatol; 2013 Oct; 54(5):330-4. PubMed ID: 23711674
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Timing of surfactant treatment in respiratory distress syndrome.
    van Kaam AH; Niemarkt HJ; Onland W
    Semin Fetal Neonatal Med; 2023 Dec; 28(6):101495. PubMed ID: 38012889
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Surfactant administration in preterm babies (28-36 weeks) with respiratory distress syndrome: LISA versus InSurE, an open-label randomized controlled trial.
    Mishra A; Joshi A; Londhe A; Deshmukh L
    Pediatr Pulmonol; 2023 Mar; 58(3):738-745. PubMed ID: 36416036
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Application of three kinds of non-invasive positive pressure ventilation as a primary mode of ventilation in premature infants with respiratory distress syndrome: a randomized controlled trial].
    Gao X; Yang B; Hei M; Cui X; Wang J; Zhou G; Qu S
    Zhonghua Er Ke Za Zhi; 2014 Jan; 52(1):34-40. PubMed ID: 24680406
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Multicenter trial of single-dose modified bovine surfactant extract (Survanta) for prevention of respiratory distress syndrome. Ross Collaborative Surfactant Prevention Study Group.
    Soll RF; Hoekstra RE; Fangman JJ; Corbet AJ; Adams JM; James LS; Schulze K; Oh W; Roberts JD; Dorst JP
    Pediatrics; 1990 Jun; 85(6):1092-102. PubMed ID: 2187176
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Surfactant replacement therapy for preterm and term neonates with respiratory distress.
    Polin RA; Carlo WA; ;
    Pediatrics; 2014 Jan; 133(1):156-63. PubMed ID: 24379227
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Surfactant therapy for respiratory distress syndrome in premature neonates: a comparative review.
    Ainsworth SB; Milligan DW
    Am J Respir Med; 2002; 1(6):417-33. PubMed ID: 14720029
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Comparison of Infasurf (calf lung surfactant extract) to Survanta (Beractant) in the treatment and prevention of respiratory distress syndrome.
    Bloom BT; Kattwinkel J; Hall RT; Delmore PM; Egan EA; Trout JR; Malloy MH; Brown DR; Holzman IR; Coghill CH; Carlo WA; Pramanik AK; McCaffree MA; Toubas PL; Laudert S; Gratny LL; Weatherstone KB; Seguin JH; Willett LD; Gutcher GR; Mueller DH; Topper WH
    Pediatrics; 1997 Jul; 100(1):31-8. PubMed ID: 9200357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.